IMMUNOLEAD

Immunolead Leaders In Immunity 1 888 917-7779 #179702

Home

Immunity

What is Immunity?

Immunity in Action

Immunity On Line

Immunity Related Studies

Glutathione

Clincal Evidence

Avemar Studies

Whey Protein Studies

Publish a Study

Submit a Study Request

Multimedia Center

Products

Avemar

Whey Protein Isolate

Whey Protein + Minerals

Medical Grade Whey

Register With Immunolead

Contact Us

Avemar Product Information

Indications: Avemar is a medical nutriment for complementing
cancer treatment during and after surgery, radiotherapy,
chemotherapy and immune therapy. The continuous use of Avemar
is recommended during the full course of clinical treatment and after
its completion for as long as recommended by the treating physician.
After surgery, the administration of Avemar can begin when the patient
has been able to take food orally and without complications for at least
4 days.

Side effects: The use of Avemar produces, on rare occasions, a soft stool
and, on even rarer occasions, an unsettled stomach or nausea.

Contraindications: Avemar should not be taken during pregnancy and
breastfeeding. Avemar should not be taken by patients undergoing
organ or tissue transplants, or those who suffer from bleeding erosions
and/or bleeding ulcers of the gastrointestinal tract (bleeding stomach
and bleeding duodenal ulcers), enteritis/colitis (serious inflammations
of the gastro-intestinal tract), or malabsorption syndrome (sprue), including
gluten sensitive enteropathies (celiac sprue). Patients with inherited
fructose intolerance or patients with hypersensitivity to any components
or ingredients of Avemar should also avoid its use.

Known interactions with other drugs: If vitamin C is being ad-ministered,
Avemar should be consumed at least 2 hours before or after treatments
with preparations containing vitamin C. As Avemar may adversely affect the
absorption of other medications or supplements, Avemar should be taken
at least 2 hours before or after treatments using other products.

Warning: Avemar is not a replacement or substitute for clinically
indicated anti-cancer therapies and procedures. Keep out of reach
of children. The medication should only be taken under medical
supervision, for patients of 14 years and older. The use of Avemar
should be discontinued 2 days before barium sulfate X-ray contrast
examinations and should not be reinstated within 2 days after the
completion of the examination! Patients with diabetes can take
Avemar under the supervision of a health professional, but the
product's carbohydrate content must be taken into consideration.

Preparation, dosage and administration:
Preparation of a single dose:
The measuring spoon included with the product measures out single
doses (9 g). Mix one level measuring spoonful of Avemar with
150 ml of cold water and drink it. Once the Avemar solution has been
made, it should be used within 30 minutes. Any unused solution should
be discarded.

Dosage: For an adult of average weight (~70 kg), a single daily
dose of 9g, prepared according to the above instructions, is
recommended, ideally approximately 1 hour before eating.
Pa-tients with a body weight of 90 kg or more should consume
two 9 g doses per day, ideally 1 hour before breakfast and supper.
Avemar can also be prepared and consumed in soft drinks or
non-carbonated mineral water, providing that their vitamin C
(as-corbic acid or E 300) content is not significant.

Web Hosting powered by Network Solutions®